Ken Griffin Viatris Inc Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Viatris Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 221,500 shares of VTRS stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

221,500

Previous 425,200 47.91%

Holding current value

$2.5 Million

Previous $5.08 Million 53.62%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.05 - $12.02 $337,981 - $404,232	33,630 Added 23.61%	176,071 $1.87 Million
Q1 2024 May 15, 2024	SELL	$11.27 - $13.53 $327,134 - $392,735	-29,027 Reduced 16.93%	142,441 $1.7 Million
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $1.35 Million - $1.67 Million	-153,728 Reduced 47.27%	171,468 $1.86 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $9.81 Million - $11.6 Million	-1,022,589 Reduced 75.87%	325,196 $3.21 Million
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $39.6 Million - $45.1 Million	-4,386,700 Reduced 76.5%	1,347,785 $13.5 Million
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $18.4 Million - $24.6 Million	-2,003,935 Reduced 25.9%	5,734,485 $55.2 Million
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $27.7 Million - $36.8 Million	-3,179,967 Reduced 29.12%	7,738,420 $86.1 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $46.4 Million - $60.9 Million	5,472,217 Added 100.48%	10,918,387 $93 Million

Others Institutions Holding VTRS

# of Institutions

1,099

Shares Held

969M

Call Options Held

2.63M

Put Options Held

2.15M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account